Insomnia and Impaired Quality of Life in the United States
- PMID: 30256547
- DOI: 10.4088/JCP.17m12020
Insomnia and Impaired Quality of Life in the United States
Abstract
Objective: This analysis characterizes the individual-level and population-level burden of insomnia in relation to other medical conditions and describes the comorbidity of insomnia with other medical conditions, including the dependence of these comorbidities on pain, life events, and mental disorders.
Methods: Information from 34,712 adults in the National Epidemiologic Survey on Alcohol and Related Conditions-III (2012-2013) was analyzed. Quality-adjusted life-years (QALYs) were measured with the SF-6D, a 6-dimensional health state classification derived from the Short-Form-12, version 2.
Results: In the last 12 months, 27.3% of adults reported insomnia. The US annual loss of QALYs associated with insomnia (5.6 million; 95% CI, 5.33-5.86 million) was significantly larger than that associated with any of the other 18 medical conditions assessed, including arthritis (4.94 million; 95% CI, 4.62-5.26 million), depression (4.02 million; 95% CI, 3.87-4.17 million), and hypertension (3.63 million; 95% CI, 3.32-3.93 million). After control for demographic factors, all conditions examined from obesity (adjusted odds ratio [aOR] = 1.25) to mania (aOR = 5.04) were associated with an increased risk of insomnia. Further controlling for pain, stressful life events, and mental disorders decreased the odds of the co-occurrence of insomnia with these conditions. The decrease in insomnia comorbidity associated with pain was greatest for fibromyalgia (31.8%) and arthritis (20.1%); the decrease in insomnia comorbidity associated with life events was greatest for mania (13.4%) and drug use disorders (11.2%); and the decrease in insomnia comorbidity associated with mental disorders was greatest for peptic ulcer disease (11.2%) and liver diseases (11.1%).
Conclusions: Insomnia is prevalent and associated with substantial population-level burden in self-assessed health. The co-occurrence of insomnia with common medical conditions is differentially related to pain and to a lesser extent to stressful life events and mental disorders.
© Copyright 2018 Physicians Postgraduate Press, Inc.
Similar articles
-
Days-out-of-role associated with insomnia and comorbid conditions in the America Insomnia Survey.Biol Psychiatry. 2011 Dec 1;70(11):1063-73. doi: 10.1016/j.biopsych.2011.08.010. Epub 2011 Oct 1. Biol Psychiatry. 2011. PMID: 21962491
-
Impairment associated with sleep problems in the community: relationship to physical and mental health comorbidity.Psychosom Med. 2008 Oct;70(8):913-9. doi: 10.1097/PSY.0b013e3181871405. Epub 2008 Oct 8. Psychosom Med. 2008. PMID: 18842741
-
Insomnia and role impairment in the community : results from the Nigerian survey of mental health and wellbeing.Soc Psychiatry Psychiatr Epidemiol. 2007 Jun;42(6):495-501. doi: 10.1007/s00127-007-0183-2. Epub 2007 Apr 21. Soc Psychiatry Psychiatr Epidemiol. 2007. PMID: 17450457
-
Prevalence, associated risks, and treatment patterns of insomnia.J Clin Psychiatry. 2005;66 Suppl 9:10-3; quiz 42-3. J Clin Psychiatry. 2005. PMID: 16336036 Review.
-
Cognitive Behavioral Therapy for Insomnia in Patients with Medical and Psychiatric Comorbidities.Sleep Med Clin. 2019 Jun;14(2):167-175. doi: 10.1016/j.jsmc.2019.01.001. Epub 2019 Mar 29. Sleep Med Clin. 2019. PMID: 31029184 Review.
Cited by
-
A comprehensive review of discovery and development of drugs discovered from 2020-2022.Saudi Pharm J. 2024 Jan;32(1):101913. doi: 10.1016/j.jsps.2023.101913. Epub 2023 Dec 10. Saudi Pharm J. 2024. PMID: 38204591 Free PMC article. Review.
-
Pharmacopuncture Effects on Insomnia Disorder: Protocol for a Multi-Site, Randomized, Acupuncture-Controlled, Clinical Trial.Int J Environ Res Public Health. 2022 Dec 12;19(24):16688. doi: 10.3390/ijerph192416688. Int J Environ Res Public Health. 2022. PMID: 36554572 Free PMC article.
-
Comparative efficacy of lemborexant and other insomnia treatments: a network meta-analysis.J Manag Care Spec Pharm. 2021 Sep;27(9):1296-1308. doi: 10.18553/jmcp.2021.21011. Epub 2021 Jun 12. J Manag Care Spec Pharm. 2021. PMID: 34121443 Free PMC article.
-
Dietary patterns and insomnia symptoms: A systematic review and meta-analysis.Sleep Med Rev. 2024 Jun;75:101936. doi: 10.1016/j.smrv.2024.101936. Epub 2024 Apr 15. Sleep Med Rev. 2024. PMID: 38714136 Free PMC article.
-
Suvorexant in the Treatment of Difficulty Falling and Staying Asleep (Insomnia).Psychopharmacol Bull. 2022 Feb 25;52(1):68-90. Psychopharmacol Bull. 2022. PMID: 35342199 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical